Early-stage venture fund founded by Bill Maris focused on AI infrastructure and computational biology.
“Network Bio, AI-powered biomarker discovery startup, raised $50 million backed by Founders Fund, Thiel Bio, Breyer Capital, and Section 32”
Source→“Biotech company Network Bio, which develops disease-specific AI models, launched with $50 million in financing.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.